We noticed that expression of G1 phase negative regulators p21CIP1 and p27KIP1 increased after dual treatment, indicating an efficient blockade of cell growth and proliferation in MM (Fig. 5C). The gene discussed is CDKN1A; the disease is Miyoshi myopathy.